Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ivermectin].

M Develoux1

  • 1Service de Parasitologie-Mycologie, Hôpital Tenon, 4, rue de la Chine, 75020 Paris. michel.develoux@tnn.ap-hop-paris.fr

Annales De Dermatologie Et De Venereologie
|August 20, 2004
PubMed
Summary
This summary is machine-generated.

Ivermectin, a macrocyclic lactone derivative, effectively treats parasitic infections like onchocerciasis and lymphatic filariasis by targeting ion channels. It shows promise for scabies, ascariasis, and head lice, with generally mild side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histoplasmosis Caused by Histoplasma capsulatum var. duboisii: A Comprehensive Review of Cases From 1993 to 2019.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Dirofilariasis: a parasitic cause of subcutaneous nodule.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Crusted cutaneous lesions requiring early diagnosis and appropriate treatment.

The Netherlands journal of medicine·2018
Same author

Imported malaria in pregnant women: report from a French University Centre.

Infection·2017
Same author

[Cancer and mycoses and literature review].

Bulletin de la Societe de pathologie exotique (1990)·2017
Same author

Imported filariasis in Europe: A series of 31 cases from Metropolitan France.

European journal of internal medicine·2016
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Pharmacology and Tropical Medicine
  • Antiparasitic drug development and application

Context:

  • Ivermectin, a semi-synthetic macrocyclic lactone, is utilized for its antiparasitic properties.
  • Its mechanism involves disrupting ion channels in nematodes and arthropods.
  • Initially used in veterinary medicine, its human applications have expanded significantly.

Purpose:

  • To review the efficacy and safety of ivermectin across various human parasitic infections.
  • To assess ivermectin's role in treating onchocerciasis, lymphatic filariasis, and other helminthic and ectoparasitic infestations.
  • To compare ivermectin with existing therapies for conditions such as scabies and strongyloidiasis.

Summary:

  • Ivermectin demonstrates microfilaricidal activity against Onchocerca volvulus and Wuchereria bancrofti, reducing microfilarial load and transmission with fewer side effects than diethylcarbamazine.

Related Experiment Videos

  • It is effective in treating Strongyloides stercoralis infections and shows potential for scabies, ascariasis, cutaneous larva migrans, and head lice.
  • While generally well-tolerated, ivermectin can induce serious adverse events like encephalopathy in Loa loa infections with high microfilaremia.

    • Impact:

    • Ivermectin has significantly reduced the prevalence of onchocerciasis and lymphatic filariasis in endemic areas through mass treatment programs.
    • It offers a safer and effective alternative to older treatments for several parasitic diseases.
    • Further research is needed to define its optimal role in scabies management, particularly for institutional outbreaks and crusted scabies.